Kevin Baillie, formerly Vice President and Head of Creative at Netflix's Eyeline Studios, has filed a lawsuit against the company. The suit alleges he was terminated from his $1.1 million per year position after revealing he had undergone medically prescribed ketamine treatment during a "Vulnerability-Trust exercise" at a January 2026 work retreat.
Baillie, known for his work on visual effects for "Pirates of the Caribbean" and the Harry Potter franchise, stated in the lawsuit that he received the ketamine treatment under medical supervision in October and November 2022. He sought this treatment for clinical depression following the death of his mother.
According to the lawsuit, Netflix launched an investigation into Baillie's comments, which he claims were made with an explanation of the medical reasons behind the treatment. The suit states that a company investigator brought up the incident in March 2026, suggesting suspicion of recreational drug use. Baillie was subsequently fired in April, with the company's attorney reportedly confirming that "the ketamine therapy issue has factored into the termination." The lawsuit also suggests Baillie was denied up to a year of severance pay.
The lawsuit also touches on other aspects of the work environment, mentioning that the investigation's scope included alleged profanity and drinking. Baillie claims he was previously advised in a performance review to "drop one or two less f-bombs but don’t stop entirely." He also described an incident at the same retreat where he drank a Guinness while standing on his head, a trick he performed after a colleague requested a demonstration. The suit further alleges an alcohol-fueled company environment encouraged by Eyeline Studios CEO Jeff Shapiro, claiming "alcohol consumption was company-sponsored, leadership-modeled and condoned."
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.
One email a day. Unsubscribe in one click, any time.
Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.
▶ Play today's briefNew every morning, and the back catalogue is archived by date.
A Netflix executive is suing the company after being fired following his disclosure of medically prescribed ketamine treatment during a work retreat trust exercise. The lawsuit claims Netflix investigated his comments, leading to his termination, and suggests the company cited the ketamine therapy as a factor.